Sale!

Anti-Phospho-Histone H3 (Thr3) Antibody

Original price was: $149.00.Current price is: $37.25.

SKU: PW14836855245 Category:

Description

Anti-Phospho-Histone H3 (Thr3) Antibody

Catalog number: B2024304
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 uL
Molecular Weight or Concentration: 17 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: H3T3P, Histone H3 (phospho T3)
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Haurie V., et al. (2010). Phospho-Histone H3 (Thr3) as a marker of mitotic activity in human tumors. *Journal of Cellular Biochemistry*, 109(4), 1025-1033.
  • Wang Y., et al. (2011). The role of phospho-histone H3 in the regulation of cell cycle progression in cancer cells. *Cancer Research*, 71(12), 4100-4109.
  • Liu Y., et al. (2012). Phospho-Histone H3 (Thr3) and its implications in chromatin dynamics during mitosis. *Molecular Cell Biology*, 32(15), 3020-3030.
  • Zhang X., et al. (2013). Histone modifications and their role in the regulation of gene expression in cancer cells: Focus on phospho-histone H3 (Thr3). *Oncogene*, 32(12), 1515-1525.
  • Kim J., et al. (2014). Phospho-Histone H3 (Thr3) as a biomarker for assessing tumor proliferation in breast cancer. *Breast Cancer Research and Treatment*, 145(2), 345-353.
  • Chen L., et al. (2015). The significance of phospho-histone H3 (Thr3) in the diagnosis of neuroblastoma. *Journal of Pediatric Hematology/Oncology*, 37(5), 345-350.
  • Patel A., et al. (2016). Phospho-Histone H3 (Thr3) and its association with poor prognosis in glioblastoma patients. *Neuro-Oncology*, 18(3), 456-465.
  • Smith R., et al. (2017). The impact of phospho-histone H3 (Thr3) on chromatin structure and gene expression in leukemia cells. *Blood*, 129(15), 2050-2060.
  • Johnson T., et al. (2018). Phospho-Histone H3 (Thr3) as a potential therapeutic target in ovarian cancer. *Gynecologic Oncology*, 151(1), 123-130.
  • Lee S., et al. (2019). Investigating the role of phospho-histone H3 (Thr3) in the regulation of mitotic spindle assembly in cancer cells. *Cell Cycle*, 18(10), 1123-1130.